-
公开(公告)号:US11578053B2
公开(公告)日:2023-02-14
申请号:US17546284
申请日:2021-12-09
Applicant: NOVARTIS AG
Inventor: Peng Fu , Yu Gai , Feng Gao , Weiyong Kong , Yadong Lu , Zhongcheng Min , Shaofeng Rong , Chutian Shu , Can Wang , Ruidong Wang , Jibin Zhao , Xianglin Zhao , Yi Zhao , Jianguang Zhou , Benjamin Martin
IPC: C07D401/06 , C07D209/04 , C07D211/74
Abstract: The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-(((2S,4S)-(4-ethoxy-1-(((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions and the use of intermediates for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US11434192B2
公开(公告)日:2022-09-06
申请号:US16452452
申请日:2019-06-25
Applicant: Novartis AG
Inventor: Florian Karl Kleinbeck-Riniker , Benjamin Martin , Gerhard Penn , Francesco Venturoni , Thierry Schlama , Thomas Ruch , Thomas Allmendinger , Bernhard Wietfeld , Paolo Filipponi
IPC: C07C59/84 , C07C67/035 , C07C213/08 , C07C69/738 , C07C313/06 , C07C229/34 , C07D265/02 , C07D207/36 , C07C251/40 , C07C251/66 , C07C51/373
Abstract: The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.
-
公开(公告)号:US10851059B2
公开(公告)日:2020-12-01
申请号:US16325880
申请日:2017-08-16
Applicant: Novartis AG
Inventor: Florian Karl Kleinbeck-Riniker , Ives Mafli , Benjamin Martin , Gerhard Penn , Gottfried Sedelmeier , Joerg Sedelmeier , Francesco Venturoni
IPC: C07C271/22 , C07D213/16 , C07C201/12 , C07C251/38 , C07C201/16 , C07C205/53 , C07C249/08 , C07D213/36 , C07C205/51 , C07C67/347 , C07C231/02 , C07C269/00 , C07C201/06 , C07C227/18 , C07C45/49 , C07C229/06 , C07C249/02 , C07D207/267 , C07D207/12
Abstract: The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril, inter alia via nitro 5 compounds. It further relates to new intermediate compounds and their use for said new chemical synthesis route, as well as a new catalyst ligand.
-
公开(公告)号:US10385004B2
公开(公告)日:2019-08-20
申请号:US15550224
申请日:2016-02-11
Applicant: Novartis AG
Inventor: Benjamin Martin , Francesca Mandrelli , Francesco Venturoni
IPC: C07C201/10 , C07C201/12 , C07C227/04 , C07C335/16 , C07F9/535 , C07D207/06 , B01J31/02 , C07C205/04 , C07C205/44 , C07C205/51 , C07F7/18
Abstract: The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.
-
公开(公告)号:US10377697B2
公开(公告)日:2019-08-13
申请号:US15780957
申请日:2016-12-08
Applicant: Novartis AG
Inventor: Florian Karl Kleinbeck-Riniker , Benjamin Martin , Gerhard Penn , Francesco Venturoni , Thierry Schlama , Thomas Ruch , Thomas Allmendinger , Bernhard Wietfeld , Paolo Filipponi
IPC: C07C51/373 , C07C69/738 , C07C313/06 , C07C229/34 , C07D265/02 , C07D207/36 , C07C251/40 , C07C251/66 , C07C59/84 , C07C67/035
Abstract: The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.
-
公开(公告)号:US11208398B2
公开(公告)日:2021-12-28
申请号:US17260393
申请日:2019-07-15
Applicant: NOVARTIS AG
Inventor: Peng Fu , Yu Gai , Feng Gao , Weiyong Kong , Yadong Lu , Zhongcheng Min , Shaofeng Rong , Chutian Shu , Can Wang , Ruidong Wang , Jibin Zhao , Xianglin Zhao , Yi Zhao , Jianguang Zhou , Benjamin Martin
IPC: C07D401/06 , C07D209/04 , C07D211/74
Abstract: The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-((2S,4S)-(4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions and the use of intermediates for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof.
-
-
-
-
-